Evidence map›Paper›PMID 37508848›Full record

ArticleBioengineering (Basel, Switzerland)2023

Exploring the Antimicrobial, Anticancer, and Apoptosis Inducing Ability of Biofabricated Silver Nanoparticles Using

Kariyellappa Nagaraja Shashiraj, Anil Hugar, Raju Suresh Kumar, Muthuraj Rudrappa, Meghashyama Prabhakara Bhat, Abdulrahman I Almansour, Karthikeyan Perumal, Sreenivasa Nayaka

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Kariyellappa Nagaraja ShashirajP.G. Department of Studies in Botany, Karnatak University, Dharwad 580003, Karnataka, India.ORCID 0000-0003-4920-6459
Anil HugarP.G. Department of Studies in Botany, Karnatak University, Dharwad 580003, Karnataka, India.ORCID 0000-0001-6826-3833
Raju Suresh KumarDepartment of Chemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0003-3754-4223
Muthuraj RudrappaP.G. Department of Studies in Botany, Karnatak University, Dharwad 580003, Karnataka, India.ORCID 0000-0003-3406-1648
Meghashyama Prabhakara BhatP.G. Department of Studies in Botany, Karnatak University, Dharwad 580003, Karnataka, India.ORCID 0000-0002-5122-9230
Abdulrahman I AlmansourDepartment of Chemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Karthikeyan PerumalDepartment of Chemistry and Biochemistry, The Ohio State University, 151 W. Woodruff Ave, Columbus, OH 43210, USA.
Sreenivasa NayakaP.G. Department of Studies in Botany, Karnatak University, Dharwad 580003, Karnataka, India.ORCID 0000-0002-7339-5715
Karnatak University · INKing Saud University · SAThe Ohio State University · US

Funding

King Saud University The project was funded by Researchers Supporting Project number (RSP2023R231) King Saud University, Riyadh, Saudi Arabia
6 · The paper itself

Abstract

Biosynthesized nano-composites, such as silver nanoparticles (AgNPs), can be engineered to function as smart nano-biomedicine platforms for the detection and management of diverse ailments, such as infectious diseases and cancer. This study determined the eco-friendly fabrication of silver nanoparticles using

Indexed as

apoptosis/necrosisbio-fabricated synthesisflow cytometryLagerstroemia speciosa flower budMG-63 cancer cell lineMTT assaysilver nanoparticles

Identifiers

PMID37508848
PMCPMC10376666
OpenAlexW4383911737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.